OncLive | Bringing the Global Oncology Community Together

The addition of atezolizumab to standard carboplatin and etoposide in the frontline setting significantly prolonged survival in patients with extensive-stage small cell lung cancer compared with the chemotherapy regimen alone. Read More >>

Brigatinib Bests Standard of Care to Improve PFS in Advanced NSCLC

Challenges Remain in Prostate Cancer Paradigm

Adding Durvalumab to Chemoradiation Improves OS in Unresectable Stage III NSCLC

Atezolizumab Regimen Improves PFS in Frontline Nonsquamous NSCLC

Neoadjuvant Immunotherapy May Change Standard of Care in Early-Stage NSCLC

View More Stories >>

View Conference Coverage

2018 International Liver Cancer Association Annual Conference

2018 International Lung Cancer Congress

2018 Pan Pacific Lymphoma Conference

2nd Annual Live Medical Crossfire® : Hematologic Malignancies

State of the Science Summit on A Summer of Progress: Updates from ASCO 2018

Dr. Cortes Discusses Quizartinib in AML

Dr. Mohile on Implementing Geriatric Assessment into Cancer Care

Dr. Pennell on the Cost Effectiveness of NGS in NSCLC

Dr. Zonder on Induction Therapy in Newly Diagnosed Multiple Myeloma

Dr. Meeks on the Genomics of Bladder Cancer

Dr. Uberti on Transplant in Myelodysplastic Syndrome

OncLive houses thousands of videos that provide updates and information.
See more Videos

Locoregional Therapies for Advanced HCC

Challenges in Managing Newly Diagnosed Advanced HCC

Immunotherapy Combinations in MSI and MSS mCRC

$Sequencing and Dosing for Refractory Colon Cancer$

Novel Treatment Strategies in Recurrent Ovarian Cancer

Management of Regional Colorectal Cancer Metastases

OncLive houses thousands of videos that provide updates and information.
See more Videos

Novel Combination Therapies Under Investigation in mRCC

Emerging TKI/I-O Options in mRCC

Establishing the Role of FLT3 Mutations in AML

Molecular Testing Through Multiple Labs in NSCLC

Adequate Tissue Collection for Molecular Testing in NSCLC

OncLive houses thousands of videos that provide updates and information.
See more Videos

Featured

Expert Anticipates Cure in Acute Lymphoblastic Leukemia

Elias Jabbour, MD, discussed recent clinical trial results in acute lymphoblastic leukemia, the role of immunotherapy, and the biggest challenges facing the field.

View more >>>

Featured

Dr. Ramchandren on the North American Results of the ECHELON-1 Study in Hodgkin Lymphoma

Radhakrishnan Ramchandren MD, associate professor, Wayne State University School of Medicine, Barbara Ann Karmanos Cancer Institute, discusses the North American results of the ECHELON-1 study in Hodgkin lymphoma.

View more >>>

Featured Video

Immunotherapy in the Treatment of Follicular Lymphoma

Ian W. Flinn, MD, PhD; Grzegorz S. Nowakowski, MD; Loretta J. Nastoupil, MD; and Anas Younes, MD, reflect on the value of immunotherapy, immunotherapy combination strategies, and understanding the tumor microenvironment in treating follicular lymphoma.View now

FDA Approval in Hairy Cell Leukemia, NDA in Urothelial Carcinoma, and 2018 ILCA Conference Highlights